DRD2 and schizophrenia: The common view is that an “optimal” level of post-synaptic dopamine D2 receptor blockade with antipsychotics attenuates dopaminergic transmission at post-synaptic neurons [4, 71], which ameliorates the positive symptoms of schizophrenia.